Xintela AB Sustainability Reports
Xintela AB specializes in developing innovative cell therapy and diagnostic solutions for regenerative medicine and cancer treatment.
Sector: Health Care
Country: Sweden
Exchange: Nasdaq Stockholm
ISIN: SE0007756903
9 reports from 2017 to 2025
Company Profile
Xintela AB
Xintela AB specializes in developing innovative cell therapy and diagnostic solutions for regenerative medicine and cancer treatment.
Reports